Study (year) | Good recovery | Death | Follow-up | Outcome measurement | Quality score |
---|---|---|---|---|---|
 | (NE/C) | (NE/C) |  |  |  |
Nakano (2003) [14] | 4/2 | 0/0 | NA | GOS | 5 |
Qiu (2003) [15] | 18/13 | 2/NA | 6 | GOS | 7 |
Cho (2006) [10] | NA | 0/4 | 6 | BI | 6 |
Zhu (2011) [16] | 7/3 | 2/5 | 3 | GOS | 7 |
Chi (2014) [17] | 111/319 | 15/14 | 3-6 | ADL | 7 |
Zhang H (2014) [11] | 11/4 | 0/3 | 6-20 | GOS | 5 |
Wang W (2015) [18] | NA | 2/1 | 6-12 | GOS | 7 |
Yamashiro (2015) [19] | 5/4 | 0/1 | NA | mRS | 6 |
Feng (2016) [12] | 60/39 | 6/8 | 6 | ADL | 6 |
Cai (2017) [20] | NA | 1/3 | Discharge | GCS | 7 |
Li Y (2017) [21] | NA | 6/8 | 6 | GOS | 7 |
Xu (2017) [22] | 30/11 | 15/18 | 6 | mRS | 7 |
Eroglu (2018) [23] | NA | 2/4 | 6 | GOS | 7 |
Zhang J (2018) [13] | 59/39 | 0/0 | 3 | GOS | 7 |